800-TEMPLE-MED Schedule Appointment

Dr. Leah Croll Offers Insight to ABC News on the FDA Granting Accelerated Approval to Leqembi for the Treatment of Early Stages of Alzheimer’s Disease

View All News

Leah Croll, MD, Assistant Professor of Clinical Neurology at the Lewis Katz School of Medicine at Temple University, offered insight to ABC News on the U.S. Food and Drug Administration (FDA) granting accelerated approval to Leqembi, which showed in a large study that it could slow the rate of cognitive decline in people with the early stages of Alzheimer’s disease.